5CLN image
Deposition Date 2015-07-16
Release Date 2016-03-09
Last Version Date 2024-01-10
Entry Detail
PDB ID:
5CLN
Keywords:
Title:
Crystal structure of a 4-oxalocrotonate tautomerase mutant at 2.7 Angstrom
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.71 Å
R-Value Free:
0.26
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:2-hydroxymuconate tautomerase
Gene (Uniprot):xylH
Mutations:M45Y, F50A
Chain IDs:A, B, C, D, E, F, G, H, I, J, K, L
Chain Length:57
Number of Molecules:12
Biological Source:Pseudomonas putida
Primary Citation
Using mutability landscapes of a promiscuous tautomerase to guide the engineering of enantioselective Michaelases.
Nat Commun 7 10911 10911 (2016)
PMID: 26952338 DOI: 10.1038/ncomms10911

Abstact

The Michael-type addition reaction is widely used in organic synthesis for carbon-carbon bond formation. However, biocatalytic methodologies for this type of reaction are scarce, which is related to the fact that enzymes naturally catalysing carbon-carbon bond-forming Michael-type additions are rare. A promising template to develop new biocatalysts for carbon-carbon bond formation is the enzyme 4-oxalocrotonate tautomerase, which exhibits promiscuous Michael-type addition activity. Here we present mutability landscapes for the expression, tautomerase and Michael-type addition activities, and enantioselectivity of 4-oxalocrotonate tautomerase. These maps of neutral, beneficial and detrimental amino acids for each residue position and enzyme property provide detailed insight into sequence-function relationships. This offers exciting opportunities for enzyme engineering, which is illustrated by the redesign of 4-oxalocrotonate tautomerase into two enantiocomplementary 'Michaelases'. These 'Michaelases' catalyse the asymmetric addition of acetaldehyde to various nitroolefins, providing access to both enantiomers of γ-nitroaldehydes, which are important precursors for pharmaceutically active γ-aminobutyric acid derivatives.

Legend

Protein

Chemical

Disease

Primary Citation of related structures